![]() |
E3330
- 英文名称:E3330
- 品牌:WYTSCI
- 产地:进口
- 型号:1MG
- 货号:WT-AY-B11048
- cas:136164-66-4
- 价格: ¥1/mg
- 发布日期: 2025-04-10
- 更新日期: 2025-05-23
产品详请
产地 | 进口 |
品牌 | WYTSCI |
货号 | WT-AY-B11048 |
用途 | 科研检测 |
英文名称 | E3330 |
包装规格 | 1MG |
CAS编号 | 136164-66-4 |
别名 | E3330 |
纯度 | 98+% |
分子式 | |
是否进口 | 是 |
纯度:>98% by HPLC,;NMR (Conforms)
分子式:C21H30O6
分子量:378.47
溶剂:DMSO (>50 mg/ml)
性状:Orange solid
存储:-20°C
Activity (short version):APE1 inhibitor/ferroptosis inducer
Function / Pharmacology:E3330 is a hepatoprotective benzoquinone that inhibits TNF-α release via decreasing NFkB activation.1,2 It also is an inhibitor of AP endonuclease 1 (APE1) redox function.3 E3330 acts synergistically with cisplatin to increase cytotoxicity and impair cell migration and invasion in non-small cell lung cancer.4 Inhibition of APE1 with E3330 induces ferroptosis via impairment of AKT phosphorylation ultimately leading to Nrf2 degradation.5 It sensitizes osteosarcoma cells to ionizing radiation via ferroptosis induction.6
分子式:C21H30O6
分子量:378.47
溶剂:DMSO (>50 mg/ml)
性状:Orange solid
存储:-20°C
Activity (short version):APE1 inhibitor/ferroptosis inducer
Function / Pharmacology:E3330 is a hepatoprotective benzoquinone that inhibits TNF-α release via decreasing NFkB activation.1,2 It also is an inhibitor of AP endonuclease 1 (APE1) redox function.3 E3330 acts synergistically with cisplatin to increase cytotoxicity and impair cell migration and invasion in non-small cell lung cancer.4 Inhibition of APE1 with E3330 induces ferroptosis via impairment of AKT phosphorylation ultimately leading to Nrf2 degradation.5 It sensitizes osteosarcoma cells to ionizing radiation via ferroptosis induction.6